Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.
Other companies in Celldex Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Xencor (NASDAQ:XNCR), Arrowhead Pharma (NASDAQ:ARWR), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Bicycle Therapeutics (NASDAQ:BCYC).
Celldex Therapeutics has a consensus price target of $65.75.
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $27.02 last updated November 22, 2024 at 4:00 PM EST.
There are no upcoming dividends for Celldex Therapeutics.
Celldex Therapeutics’s Q4 earnings are confirmed for Monday, February 24, 2025.
There is no upcoming split for Celldex Therapeutics.
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.